Loading company…
TopiVert develops topical kinase inhibitors for inflammatory conditions of the eye and gut.
TopiVert is based in London, UK, and focuses on discovering topical kinase inhibitors for inflammatory conditions of the eye and gut. The company is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in